HealthProves
Inicio/Fabricantes/Chain Drug Consortium, LLC
Perfil del fabricante

Chain Drug Consortium, LLC

Compañía farmacéutica2 productos registrados
2
productos registrados
48.108
notificaciones totales
64
retiradas registradas
67,6%
graves en total
Productos
mostrando 2 de 2
ProductoAprobadoNotificaciones ↓Señal principalRetiradas
—46.895Pénfigo64
—1213Sensación de ardor vulvovaginal0
Historial de retiradas · 50 registradas
FechaClaseMotivoEmpresa
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
28 may 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
19 dic 2025IIFailed Disintegration Specifications: above the time expected.Sato Pharmaceutical Co., Ltd
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
2 dic 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
23 jun 2022IICGMP Deviations: product held outside appropriate storage temperature conditions.Family Dollar Stores, Llc.
26 ene 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 ene 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 ene 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 ene 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
26 ene 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
24 ene 2022IIcGMP deviationsUltra Seal Corporation
24 ene 2022IIcGMP deviationsUltra Seal Corporation
28 may 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 may 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 may 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
28 may 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
6 nov 2018IIPresence of foreign substance: Product found to contain metal particles.L. Perrigo Company
7 may 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
7 may 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
30 mar 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
30 mar 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
30 mar 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
16 abr 2015IIProducts failed the Antimicrobial Effectiveness Test.Tarmac Products, Inc.

Clase I = probabilidad razonable de daño grave · Clase II = temporal o reversible · Clase III = improbable que cause daño.

Estado de registro

Algunos productos de Chain Drug Consortium, LLC no están registrados por la FDA para uso humano. Para las sustancias no registradas (péptidos, SARM sin registro humano) no existe ningún proveedor legítimo para uso humano. La ausencia de una vía de aprovisionamiento es la información de seguridad.